Galactomannan detection for invasive aspergillosis in immunocompromized patients (Q24240734)

1

0 references

Johannes B Reitsma

Christina Vandenbroucke-Grauls

7

object named as

Johannes B Reitsma

0 references

9

object named as

Christina M Vandenbroucke-Grauls

0 references

author name string

Yvette J Debets-Ossenkopp

2

0 references

Caroline E Visser

3

0 references

Rob JPM Scholten

4

0 references

Henk A Bijlmer

6

0 references

Patrick MM Bossuyt

Cochrane Database of Systematic Reviews

8

0 references

publication date

7 October 2008

0 references

published in

0 references

cites work

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

The contribution of galactomannan detection in the diagnosis of invasive aspergillosis in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus antigen testing in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Multicenter evaluation of an enzyme immunoassay (Platelia Aspergillus) for the detection of Aspergillus antigen in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Non-culture based diagnostic tests for mycotic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Invasive aspergillosis: results of an 8-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Reliability of clinical research on invasive fungal infections: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Laboratory diagnosis of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Invasive aspergillosis in 2002: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Towards a targeted, risk-based, antifungal strategy in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Current approaches to diagnosis and treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Galactomannan antigen detection in the diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

No role for quality scores in systematic reviews of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Value of antigen detection in predicting invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

Frequent false-positive results of Aspergillus latex agglutination test: transient Aspergillus antigenemia during neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Meta-analysis of diagnostic test accuracy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Non-value of Aspergillus antigen detection in bronchoalveolar lavage fluids of patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

Evaluation of sandwich ELISA galactomannan test in samples of positive LA test and positive aspergillus antibody

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007394

7 January 2021

10.1002/14651858.CD007394

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2598038

OpenCitations bibliographic resource ID

2598038

1 reference